The order scrutinizes both pharmaceutical manufacturers and foreign countries where brand-name drugs are often available to patients at significantly cheaper prices than in the United States.

Trump signed an executive order on May 12 aimed at lowering drug prices to better match what other countries charge.

A 2024 report published by the RAND research organization found, using 2022 data, that prices in the U.S. were 2.78 times higher than those in 33 comparable countries across all drugs.